International Conference on
Nanomedicine & Nanotechnology

CEO of the World Nano Foundation, situated in the United States.

Nanomedicine, Naotechnology

Professor at Deakin University, Australia

Nanomedicine

Assistant Director at Petrochemical company, Egypt

Nanomedicine/Nanotechnology

Chairperson and Professor at University of Idaho, USA

Nanomedicine/Nanotechnology

Professor at Technological Institute of Aguascaliente, Mexico

Nanomedicine and Nanotechnology

CEO and Professor at The London BioScience Innovation Centre, London

Nanomedicine and Nanotechnology

Director at Drug Development NantBioScience, USA

Drug Delivery and Development

Director at Fluorotronics Inc.,USA

Nanomedicine and Nanotechnology

Director at Fluorotronics Inc.,USA

Nanomedicine and Nanotechnology

Head of the Laboratory of Environmental Chemometrics at University of Gdansk, Poland

Nanotechnology

Principal investigator at Centre for Neuroscience and Cell Biology, Portugal

Neuroscience and Cell Biology

Chairman of Forensic Medicine & Toxicology Department Beni Suef University, Egypt

Medicine & Toxicology

Assistant Professor at Western Sydney University, Australia

Nanomedicine and Nanotechnology

DR. ALAIN L. FYMAT, BA, BS, MA, MS, PhD, PhD is a medical-physical scientist and an educator. He is the current President/CEO and Institute Professor at the International Institute of Medicine & Science with a previous appointment as Executive Vice President/Chief Operating Officer and Professor at the Weil Institute of Critical Care Medicine, California, U.S.A. He was formerly Professor of Radiology, Radiological Sciences, Radiation Oncology, Critical Care Medicine and Physics at several U.S. and European Universities. Earlier, he was Deputy Director (Western Region) of the U.S. Department of Veterans Affairs (Office of Research Oversight). At the Loma Linda Veterans Affairs Medical Center, he was Scientific Director of Radiology, Director of the Magnetic Resonance Imaging Center and, for a time, Acting Chair of Radiology. Previously, he was also Director of the Division of Biomedical and Biobehavioral Research at the University of California at Los Angeles/Drew University of Medicine and Science and an Advisor to the U.S. National Academy of Sciences, National Research Council, for postdoctoral programs tenable at the California Institute of Technology. He is Health Advisor to the American Heart & Stroke Association, Coachella Valley Division, California. He is a frequent Keynote Speaker and International Organizing Committee Member of several international scientific conferences. He has lectured extensively in the U.S., Europe, Asia and Africa. He has published ~ 425 scholarly scientific publications and books. He is also Editor-in-Chief, Honorable Editor or Editor of 72 medical/scientific Journals to which he contributes regularly. Dr. Fymat is a Board member of several institutions, a professional member of the New York Academy of Sciences and the European Academy of Sciences, and a reviewer for the prestigious UNESCO Newton Prize, United Kingdom National Commission for UNESCO. His current research interests are focused on neurodegenerative diseases (Alzheimer, Parkinson, epilepsy, dementias and others), oncology, molecular/precision/personalized medicine, and nanomedicine and nanobiotechnology.

Neurodegenerative Diseases (Alzheimer, Parkinson, Epilepsy, Dementia, and others), Oncology, Molecular/Precision/Personalized Medicine, and Nanomedicine and Nano-biotechnology.